Maher Khdour

1.3k total citations
56 papers, 947 citations indexed

About

Maher Khdour is a scholar working on Geriatrics and Gerontology, General Health Professions and Family Practice. According to data from OpenAlex, Maher Khdour has authored 56 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Geriatrics and Gerontology, 10 papers in General Health Professions and 10 papers in Family Practice. Recurrent topics in Maher Khdour's work include Pharmaceutical Practices and Patient Outcomes (17 papers), Medication Adherence and Compliance (10 papers) and Diabetes Management and Education (6 papers). Maher Khdour is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (17 papers), Medication Adherence and Compliance (10 papers) and Diabetes Management and Education (6 papers). Maher Khdour collaborates with scholars based in Palestinian Territory, Jordan and United Arab Emirates. Maher Khdour's co-authors include Anan S. Jarab, Tareq L. Mukattash, James C. McElnay, Joseph C. Kidney, Hussein Hallak, Ahmed F. Hawwa, Rana Abu Farha, Ahmad Al‐Azayzih, Ashley Agus and Grainne Crealey and has published in prestigious journals such as The Lancet, PLoS ONE and British Journal of Clinical Pharmacology.

In The Last Decade

Maher Khdour

48 papers receiving 918 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maher Khdour Palestinian Territory 17 248 245 190 182 179 56 947
Inge Van Tongelen Belgium 17 313 1.3× 278 1.1× 269 1.4× 347 1.9× 99 0.6× 33 1.0k
Sunny A. Linnebur United States 22 114 0.5× 298 1.2× 174 0.9× 117 0.6× 225 1.3× 75 1.4k
J. Lars G. Nilsson Sweden 18 220 0.9× 313 1.3× 343 1.8× 209 1.1× 142 0.8× 33 897
J. Mark Ruscin United States 16 69 0.3× 227 0.9× 109 0.6× 88 0.5× 155 0.9× 23 1.0k
Abdulla Shehab United Arab Emirates 18 64 0.3× 223 0.9× 232 1.2× 70 0.4× 143 0.8× 68 1.2k
Teerapon Dhippayom Thailand 18 73 0.3× 229 0.9× 300 1.6× 159 0.9× 252 1.4× 69 1.3k
Isabelle Arnet Switzerland 19 163 0.7× 359 1.5× 586 3.1× 135 0.7× 119 0.7× 89 1.2k
Geert W. ‘t Jong Netherlands 20 102 0.4× 192 0.8× 57 0.3× 116 0.6× 193 1.1× 32 1.2k
Marion Schaefer Germany 16 80 0.3× 407 1.7× 132 0.7× 36 0.2× 154 0.9× 53 1.0k
Michael W. Shannon United States 21 221 0.9× 201 0.8× 56 0.3× 136 0.7× 155 0.9× 42 1.8k

Countries citing papers authored by Maher Khdour

Since Specialization
Citations

This map shows the geographic impact of Maher Khdour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maher Khdour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maher Khdour more than expected).

Fields of papers citing papers by Maher Khdour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maher Khdour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maher Khdour. The network helps show where Maher Khdour may publish in the future.

Co-authorship network of co-authors of Maher Khdour

This figure shows the co-authorship network connecting the top 25 collaborators of Maher Khdour. A scholar is included among the top collaborators of Maher Khdour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maher Khdour. Maher Khdour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Qerem, Walid, et al.. (2025). Novel pharmaceutical treatment approaches for schizophrenia: a systematic literature review. European Journal of Clinical Pharmacology. 81(4). 525–541.
2.
Al‐Qerem, Walid, et al.. (2025). Parental numeracy skills and asthma control: a cross-sectional study. Journal of Asthma. 62(10). 1768–1775. 1 indexed citations
3.
Al‐Qerem, Walid, et al.. (2025). Public knowledge, attitudes, practices, and barriers to skin cancer screening in the United Arab Emirates. PLoS ONE. 20(1). e0316613–e0316613. 1 indexed citations
4.
Jarab, Anan S., et al.. (2024). Pharmacists’ Knowledge about Chronic Kidney Disease and its Management: Exploring Gaps and the Associated Factors. Jordan Journal of Pharmaceutical Sciences. 17(4). 675–686.
5.
Jarab, Anan S., Suhaib Muflih, Walid Al‐Qerem, et al.. (2024). Medication non-adherence among outpatients with myocardial infarction: A hospital-based study. Clinical Epidemiology and Global Health. 28. 101682–101682.
6.
Al‐Qerem, Walid, Anan S. Jarab, Maher Khdour, et al.. (2024). Assessing mental health literacy in Jordan: a factor analysis and Rasch analysis study. Frontiers in Public Health. 12. 1396255–1396255. 6 indexed citations
7.
Al‐Jumaili, Ali Azeez, et al.. (2023). Factors impacting job satisfaction among pharmacists in the Arab world: A qualitative study. Saudi Pharmaceutical Journal. 31(4). 578–584. 7 indexed citations
8.
Jarab, Anan S., et al.. (2022). Public Perception of Pharmacist's Role during COVID-19 Outbreak in Jordan. Jordan Journal of Pharmaceutical Sciences. 15(3). 365–377. 6 indexed citations
9.
Khdour, Maher, et al.. (2021). Online self-medication practices among university students in Palestine: a questionnaire-based study. Jordan Journal of Pharmaceutical Sciences. 14(3). 1 indexed citations
10.
Mukattash, Tareq L., Anan S. Jarab, Rana Abu Farha, et al.. (2020). Willingness and readiness to test for COVID‐19; A qualitative exploration of community pharmacists. International Journal of Clinical Practice. 74(12). e13620–e13620. 15 indexed citations
11.
Khdour, Maher, et al.. (2019). Assessment of the inhalation technique and adherence to therapy and their effect on disease control in outpatients with asthma. Journal of Pharmaceutical Health Services Research. 10(3). 353–358. 6 indexed citations
12.
13.
Khdour, Maher, et al.. (2017). Knowledge of Cardiovascular Disease among Undergraduate University Students in Palestine. Journals & Books Hosting (International Knowledge Sharing Platform). 7(4). 75–81. 4 indexed citations
14.
Khdour, Maher, et al.. (2016). Pharmacovigilance and Adverse Drug Reactions Reporting Process in West-Bank, Palestine. 1(2). 41–48. 1 indexed citations
15.
Mukattash, Tareq L., et al.. (2016). Prevalence and nature of off-label antibiotic prescribing for children in a tertiary setting: A descriptive study from Jordan. Pharmacy Practice. 14(3). 725–725. 19 indexed citations
16.
Jarab, Anan S., et al.. (2014). Predictors of non-adherence to pharmacotherapy in patients with type 2 diabetes. International Journal of Clinical Pharmacy. 36(4). 725–733. 40 indexed citations
17.
Khdour, Maher, et al.. (2013). Prevalence, awareness, treatment and control of hypertension in the Palestinian population. Journal of Human Hypertension. 27(10). 623–628. 41 indexed citations
18.
Khdour, Maher, et al.. (2012). Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD). European Journal of Clinical Pharmacology. 68(10). 1365–1373. 106 indexed citations
19.
Khdour, Maher, et al.. (2011). Extent and nature of unlicensed and off-label medicine use in hospitalised children in Palestine. International Journal of Clinical Pharmacy. 33(4). 650–655. 34 indexed citations
20.
Khdour, Maher, et al.. (2009). Clinical pharmacy‐led disease and medicine management programme for patients with COPD. British Journal of Clinical Pharmacology. 68(4). 588–598. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Inge Van Tongelen Breakdown of academic impact, for papers by Sunny A. Linnebur Breakdown of academic impact, for papers by J. Lars G. Nilsson Breakdown of academic impact, for papers by J. Mark Ruscin Breakdown of academic impact, for papers by Abdulla Shehab Breakdown of academic impact, for papers by Teerapon Dhippayom Breakdown of academic impact, for papers by Isabelle Arnet Breakdown of academic impact, for papers by Geert W. ‘t Jong Breakdown of academic impact, for papers by Marion Schaefer Breakdown of academic impact, for papers by Michael W. Shannon
Rankless by CCL
2026